Bates Ruth E, Omer Mohamed, Abdelmoneim Sahar S, Arruda-Olson Adelaide M, Scott Christopher G, Bailey Kent R, McCully Robert B, Pellikka Patricia A
Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Mayo Clin Proc. 2016 Nov;91(11):1535-1544. doi: 10.1016/j.mayocp.2016.07.013. Epub 2016 Oct 6.
To evaluate the impact of screening stress testing for coronary artery disease in asymptomatic patients with diabetes in a community-based population.
This observational study included 3146 patients from Olmsted County, Minnesota, with no history of coronary artery disease or cardiac symptoms in whom diabetes was newly diagnosed from January 1, 1992, through December 31, 2008. With combined all-cause mortality and myocardial infarction as the primary outcome, weighted Cox proportional hazards regression was performed with screening stress testing within 2 years of diabetes diagnosis as the time-dependent covariate. For descriptive analysis, participants were classified by their clinical experience during the first 2 years postdiagnosis as screened (asymptomatic, underwent stress test), unscreened (asymptomatic, no stress test), or symptomatic (experienced symptoms or event).
Among the screened and unscreened participants, 54% (1358 of 2538) were men; the mean (SD) age at diabetes diagnosis was 55 years (13.8 years), and 97% (2442 of 2520) had type 2 diabetes. In event-free survival analysis, 292 patients comprised the screened cohort and 2246 patients comprised the unscreened cohort. Death or myocardial infarction occurred in 454 patients (32 patients in the screened cohort and 422 in the unscreened cohort [5-year rate, 1.9% and 5.3%, respectively]) during median (interquartile range) follow-up of 9.1 years (5.3-12.5 years). Screening stress testing was associated with improved event-free survival (hazard ratio, 0.61; P=.004), independent of cardiac risk factors. However, while stress test results were abnormal in 47 of the 292 screened patients (16%), only 6 (2%) underwent coronary revascularization.
Although screening cardiac stress testing in asymptomatic patients with diabetes in this community-based population was associated with improvement in long-term event-free survival, this result does not appear to occur by coronary revascularization alone.
评估在以社区为基础的人群中,对无症状糖尿病患者进行冠状动脉疾病筛查性负荷试验的影响。
这项观察性研究纳入了明尼苏达州奥尔姆斯特德县的3146例患者,这些患者无冠状动脉疾病史或心脏症状,于1992年1月1日至2008年12月31日期间新诊断为糖尿病。以全因死亡率和心肌梗死合并作为主要结局,将糖尿病诊断后2年内进行的筛查性负荷试验作为时间依赖性协变量,进行加权Cox比例风险回归分析。为进行描述性分析,根据诊断后前2年的临床经历,将参与者分为已筛查组(无症状,接受了负荷试验)、未筛查组(无症状,未进行负荷试验)或有症状组(出现症状或事件)。
在已筛查和未筛查的参与者中,54%(2538例中的1358例)为男性;糖尿病诊断时的平均(标准差)年龄为55岁(13.8岁),97%(2520例中的2442例)患有2型糖尿病。在无事件生存分析中,292例患者组成已筛查队列,2246例患者组成未筛查队列。在中位(四分位间距)9.1年(5.3 - 12.5年)的随访期间,454例患者发生死亡或心肌梗死(已筛查队列中有32例,未筛查队列中有422例[5年发生率分别为1.9%和5.3%])。筛查性负荷试验与改善无事件生存相关(风险比,0.61;P = 0.004),独立于心脏危险因素。然而,在292例已筛查患者中,47例(16%)的负荷试验结果异常,但仅6例(2%)接受了冠状动脉血运重建。
尽管在这个以社区为基础的人群中,对无症状糖尿病患者进行心脏负荷试验筛查与长期无事件生存的改善相关,但这一结果似乎并非仅通过冠状动脉血运重建实现。